Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

is an oomycete that causes late blight disease in multiple solanaceous crops, including potato and tomato. This makes it a worldwide concern for farmers, given the level of crop loss and its explosive epidemic potential. Although fungicides have traditionally been used for managing this disease, populations of resistant to fungicides have been documented. Furthermore, it has been shown that isolates considered originally sensitive to mefenoxam acquire resistance to it after a single exposure to low concentrations of this widely used fungicide. Previous studies have measured such resistance in terms of mycelial growth. However, there is still much unknown regarding how this phenomenon is triggered. Here, we explored the dynamics of how this resistance is gained and lost, both in terms of mycelial growth and sporangial production. Isolates that acquired resistance to mefenoxam: i) did not sporulate significantly more than they did before, ii) were not affected by repeated exposures to a high concentration of mefenoxam, iii) lost the acquired resistance after a single passage through medium without mefenoxam, and iv) re-acquired the resistance after a single re-exposure to a low concentration of mefenoxam. Such dynamic behavior aligns well with the pleiotropic drug resistance mechanism that has been proposed as the molecular process behind the acquired resistance phenomenon, as well as with an epigenetic mode of regulation. This study narrows our knowledge gap on this phenomenon and reinforces the importance of deciphering whether it could be an issue under field conditions.

Download full-text PDF

Source
http://dx.doi.org/10.1094/PDIS-05-25-1110-REDOI Listing

Publication Analysis

Top Keywords

resistance single
12
acquired resistance
12
resistance
9
terms mycelial
8
mycelial growth
8
concentration mefenoxam
8
mefenoxam
6
mefenoxam sensitive
4
sensitive isolates
4
isolates acquire
4

Similar Publications

Aim: To investigate the phenotypic and genomic features of three multidrug-resistant (MDR) clinical mucoid and non-mucoid uropathogenic Escherichia coli (UPEC) strains to understand their antimicrobial resistance, biofilm formation, and virulence in urinary tract infections (UTIs).

Methods And Results: The UPEC strains A5, A10, and A15 were isolated from two UTI patients. Phenotypic assays included colony morphology, antibiotic susceptibility, motility, and biofilm formation.

View Article and Find Full Text PDF

Strain sensors have received considerable attention in personal healthcare due to their ability to monitor real-time human movement. However, the lack of chemical sensing capabilities in existing strain sensors limits their utility for continuous biometric monitoring. Although the development of dual wearable sensors capable of simultaneously monitoring human motion and biometric data presents significant challenges, the ability to fabricate these sensors with geometries tailored to individual users is highly desirable.

View Article and Find Full Text PDF

Bacterial leaf streak (BLS), caused by pv. (), has recently emerged as a significant threat to wheat production in the Northern Great Plains region of the US. Deploying resistant cultivars is an economical and practical method of controlling BLS.

View Article and Find Full Text PDF

Antibody-based therapies have revolutionized cancer treatment but have several limitations. These include: down-regulation of the target antigen; mutation of the target epitope; or in the case of antibody drug conjugates (ADCs), resistance to the chemotherapy warhead. Since TROP2-targeted therapy with ADCs yields responses in TROP2+ solid tumors but lacks the durability observed with other immunotherapy-based approaches, we developed novel TROP2-targeting chimeric antigen receptor (CAR) T cells as an alternative.

View Article and Find Full Text PDF

Pancreatic ductal adenocarcinoma (PDA) is defined by a myeloid-enriched microenvironment and has shown remarkable resistance to immune checkpoint blockade (e.g., PD-1 and CTLA-4).

View Article and Find Full Text PDF